Clinton H. Seversonclint
Chairman & Chief Executive Officer


Clinton H. Severson has served as Chief Executive Officer & Director of Abaxis since June 1996. He was appointed to Chairman of the Board in May 1998. From June 1996 until April 2015, Mr. Severson also served as President. Mr. Severson was selected as a Director because of his in-depth knowledge of operations, finance and strategy in his position as CEO, along with his extensive senior management experience in medical diagnostics and experience serving on the Boards of Directors of various public and private companies. Over 20 years, he grew Abaxis from 50 Million to 1.2 Billion in Market Capitalization.


Clinton will be one of the distinguished speakers at the 8th Annual Life Science Chief Executive Officer Forum.


What is one thing you hope to learn or discuss with your peers at the forum?  
Trends in health care from the point of view of the others.


What company initiatives are on the horizon for your team in 2017?
Lots of new product development and new product launches.


What do you believe are the 3 biggest factors impacting the life science industry today?

  1. Reimbursement
  2. Regulation
  3. Demographics (ageing to the population)


What are the greatest opportunities for life science companies over the next 5 years? 
Innovation in developing more cost effective products and processes.


From a leadership standpoint, where do you draw your inspiration?  
From the Abaxis employees


If you could describe your company in one word, what would that be?